Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

FRANKFURT, Germany, Dec. 9, 2024 /PRNewswire/ — Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group (“Zentiva”), completed the voluntary public purchase offer for the shares of APONTIS PHARMA AG (“APONTIS…